BCRX Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

$10.22  -0.19 (-1.78%)
As of 04/09/2021 15:59:44 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/07/2001
Outstanding shares:  177,521,693
Average volume:  6,182,453
Market cap:   $1,812,496,486
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09058V103
ISIN:        US09058V1035
Sedol:      2100362
Valuation   (See tab for details)
PE ratio:   -9.91
PB ratio:   53.46
PS ratio:   101.76
Return on equity:   949.09%
Net income %:   -1,026.35%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy